Oscar Health (NYSE:OSCR) Insider Sells $325,822.00 in Stock

Key Points

• Oscar Health insider Janet Liang sold 10,360 shares for $325,822, reducing her direct ownership by 4% to 248,697 shares. The sale occurred under a Rule 10b5-1 plan to cover tax obligations tied to vested equity awards.
• Oscar Health recently reported strong quarterly results, with EPS of $1.10 versus the $0.40 consensus estimate and revenue of $4.88 billion, up 70.4% year over year.
• OSCR shares traded at $32.90, near their 52-week high, while analysts maintained an overall “Hold” rating with an average price target of $26.22; institutional investors own 75.7% of the company.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Janet Liang sold 10,360 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $325,822.00. Following the sale, the insider directly owned 248,697 shares in the company, valued at $7,821,520.65. This trade represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

OSCR stock traded up $0.65 during midday trading on Tuesday, hitting $32.90. 4,754,751 shares of the stock traded hands, compared to its average volume of 7,062,275. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $33.55. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The stock's fifty day simple moving average is $30.49 and its 200-day simple moving average is $22.87. The firm has a market cap of $10.15 billion, a P/E ratio of 23.50, a PEG ratio of 0.66 and a beta of 2.37.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company's revenue for the quarter was up 70.4% on a year-over-year basis. During the same period in the prior year, the company posted ($0.89) EPS. On average, analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently made changes to their positions in OSCR. Nykredit A S acquired a new stake in shares of Oscar Health in the second quarter worth approximately $130,000. California State Teachers Retirement System raised its stake in Oscar Health by 3,214.2% in the 2nd quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company's stock valued at $222,543,000 after purchasing an additional 7,567,600 shares during the last quarter. Comprehensive Financial Planning Inc. PA purchased a new position in Oscar Health in the 2nd quarter valued at $309,000. AXQ Capital LP acquired a new stake in Oscar Health during the 2nd quarter worth $1,059,000. Finally, Wellington Management Group LLP boosted its stake in Oscar Health by 65.6% during the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock worth $17,217,000 after purchasing an additional 239,109 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Zacks Research upgraded Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th. Piper Sandler reissued an "overweight" rating and issued a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. Wall Street Zen raised shares of Oscar Health from a "buy" rating to a "strong-buy" rating in a report on Sunday, June 14th. UBS Group upped their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the stock a "neutral" rating in a research report on Friday, August 7th. Finally, The Goldman Sachs Group reaffirmed a "neutral" rating and set a $30.00 price objective on shares of Oscar Health in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of "Hold" and an average target price of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.